Lingua: Inglese
Editore: Martin Luther King Fellows Press, 2000
ISBN 10: 0937644048 ISBN 13: 9780937644041
Da: Hawking Books, Edgewood, TX, U.S.A.
Condizione: Good. Meets or exceeds the good condition guidelines. Nice copy. Tear on cover. Five star seller - Buy with confidence!
Da: Antiquariat Thomas Haker GmbH & Co. KG, Berlin, Germania
Membro dell'associazione: GIAQ
Prima edizione
EUR 10,00
Quantità: 1 disponibili
Aggiungi al carrelloHardcover/Pappeinband. Condizione: Wie neu. 1st ed. 600 p. : num. ill. ; 25,4 cm. Like new. Shrink wrapped. / Wie neu. In Folie verschweißt. Sprache: Englisch Gewicht in Gramm: 1250.
Da: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Germania
EUR 39,00
Quantità: 1 disponibili
Aggiungi al carrello2007th ed. 18 x 25 cm. 481 pages. Hardcover. gm5 Sprache: Englisch.
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. xi + 469 1st Edition.
Da: Majestic Books, Hounslow, Regno Unito
EUR 69,44
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. pp. xi + 469 Illus.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 70,30
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. pp. xi + 469.
Da: UK BOOKS STORE, London, LONDO, Regno Unito
EUR 122,56
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
Da: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Da: Basi6 International, Irving, TX, U.S.A.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Da: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 225,35
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition.
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 256,36
Quantità: 15 disponibili
Aggiungi al carrelloCondizione: New. Gene Therapy for Cancer Editor(s): Hunt, Kelly K. (The University of Texas, Houston, TX, USA); Vorburger, Stephan A.; Swisher, Stephen G. Series: Cancer Drug Discovery and Development. Num Pages: 481 pages, 69 black & white illustrations, 16 colour illustrations, 26 black & white tables, biograp. BIC Classification: MJCL; MJZ. Category: (P) Professional & Vocational. Dimension: 254 x 178 x 23. Weight in Grams: 1204. . 2007. Hardback. . . . .
Da: preigu, Osnabrück, Germania
EUR 202,80
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Gene Therapy for Cancer | Kelly K. Hunt (u. a.) | Taschenbuch | xii | Englisch | 2010 | Humana Press | EAN 9781617375903 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Da: Revaluation Books, Exeter, Regno Unito
EUR 309,08
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 469 pages. 10.25x7.25x0.75 inches. In Stock.
Da: Kennys Bookstore, Olney, MD, U.S.A.
Condizione: New. Gene Therapy for Cancer Editor(s): Hunt, Kelly K. (The University of Texas, Houston, TX, USA); Vorburger, Stephan A.; Swisher, Stephen G. Series: Cancer Drug Discovery and Development. Num Pages: 481 pages, 69 black & white illustrations, 16 colour illustrations, 26 black & white tables, biograp. BIC Classification: MJCL; MJZ. Category: (P) Professional & Vocational. Dimension: 254 x 178 x 23. Weight in Grams: 1204. . 2007. Hardback. . . . . Books ship from the US and Ireland.
Condizione: New. pp. 600.
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 330,20
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Da: Revaluation Books, Exeter, Regno Unito
EUR 428,52
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 600 pages. 10.00x7.00x1.00 inches. In Stock.
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 429,14
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 182,29
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Da: moluna, Greven, Germania
EUR 175,51
Quantità: Più di 20 disponibili
Aggiungi al carrelloGebunden. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Vectors used in gene therapy for cancerCharacteristics and production methods of cancer gene vectorsTargets and specific approaches for the therapy of cancerClinical applications of cancer gene therapyBackground knowledge, tec.
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 213,99
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The three sections of this volume present currently available cancer gene therapy techniques. Part I describes the various aspects of gene delivery. In Part II, the contributors discuss strategies and targets for the treatment of cancer. Finally, in Part III, experts discuss the difficulties inherent in bringing gene therapy treatment for cancer to the clinic. This book will prove valuable as the volume of preclinical and clinical data continues to increase. 484 pp. Englisch.
Da: moluna, Greven, Germania
EUR 192,60
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Vectors used in gene therapy for cancerCharacteristics and production methods of cancer gene vectorsTargets and specific approaches for the therapy of cancerClinical applications of cancer gene therapyBackground knowledge, tec.
Da: preigu, Osnabrück, Germania
EUR 181,95
Quantità: 5 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Gene Therapy for Cancer | Kelly K. Hunt (u. a.) | Buch | xii | Englisch | 2007 | Humana Press | EAN 9781588294722 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 235,39
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The three sections of this volume present currently available cancer gene therapy techniques. Part I describes the various aspects of gene delivery. In Part II, the contributors discuss strategies and targets for the treatment of cancer. Finally, in Part III, experts discuss the difficulties inherent in bringing gene therapy treatment for cancer to the clinic. This book will prove valuable as the volume of preclinical and clinical data continues to increase. 484 pp. Englisch.
Lingua: Inglese
Editore: Humana Press, Humana Press Feb 2007, 2007
ISBN 10: 1588294722 ISBN 13: 9781588294722
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 213,99
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The possibility of treating cancer, a disease defined by genetic defects, by introducing genes targeting these very alterations has led to an immense interest in gene therapy for cancer. Although incremental successes have been realized, enthusiasm for gene therapy has declined due to an increasing number of obstacles. These obstacles include vector systems that do not reach systemic metastases, therapeutic genes with redundant mec- nisms allowing for cellular resistance, and toxicities in clinical trials leading to premature closure of these studies. Different tactics to overcome or circumvent these obstacles have catalyzed the development of a wide range of gene therapy approaches. Thus far, almost two-thirds of gene therapy trials have focused on cancer. This reflects the concept that gene therapy approaches for the treatment of cancer do not necessarily require long-term expression of the gene as is necessary for the treatment of primary genetic defects like hemophilia or juvenile diabetes. Unlike the treatment of genetic defects, where expr- sion of the corrected gene needs to be strong, permanent and, sometimes regulated, tactics to treat tumors can be based on temporary and locally limited effects. In addition, cancer cells have different properties than normal cells and this allows for targeting gene therapy to specific cells, a major advantage over current antitumor therapies, which are also toxic to normal cells and tissues.Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 484 pp. Englisch.
Lingua: Inglese
Editore: Humana Press, Humana Press, 2007
ISBN 10: 1588294722 ISBN 13: 9781588294722
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 219,37
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The possibility of treating cancer, a disease defined by genetic defects, by introducing genes targeting these very alterations has led to an immense interest in gene therapy for cancer. Although incremental successes have been realized, enthusiasm for gene therapy has declined due to an increasing number of obstacles. These obstacles include vector systems that do not reach systemic metastases, therapeutic genes with redundant mec- nisms allowing for cellular resistance, and toxicities in clinical trials leading to premature closure of these studies. Different tactics to overcome or circumvent these obstacles have catalyzed the development of a wide range of gene therapy approaches. Thus far, almost two-thirds of gene therapy trials have focused on cancer. This reflects the concept that gene therapy approaches for the treatment of cancer do not necessarily require long-term expression of the gene as is necessary for the treatment of primary genetic defects like hemophilia or juvenile diabetes. Unlike the treatment of genetic defects, where expr- sion of the corrected gene needs to be strong, permanent and, sometimes regulated, tactics to treat tumors can be based on temporary and locally limited effects. In addition, cancer cells have different properties than normal cells and this allows for targeting gene therapy to specific cells, a major advantage over current antitumor therapies, which are also toxic to normal cells and tissues.
Lingua: Inglese
Editore: Humana Press, Humana Press Dez 2010, 2010
ISBN 10: 161737590X ISBN 13: 9781617375903
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 235,39
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The possibility of treating cancer, a disease defined by genetic defects, by introducing genes targeting these very alterations has led to an immense interest in gene therapy for cancer. Although incremental successes have been realized, enthusiasm for gene therapy has declined due to an increasing number of obstacles. These obstacles include vector systems that do not reach systemic metastases, therapeutic genes with redundant mec- nisms allowing for cellular resistance, and toxicities in clinical trials leading to premature closure of these studies. Different tactics to overcome or circumvent these obstacles have catalyzed the development of a wide range of gene therapy approaches. Thus far, almost two-thirds of gene therapy trials have focused on cancer. This reflects the concept that gene therapy approaches for the treatment of cancer do not necessarily require long-term expression of the gene as is necessary for the treatment of primary genetic defects like hemophilia or juvenile diabetes. Unlike the treatment of genetic defects, where expr- sion of the corrected gene needs to be strong, permanent and, sometimes regulated, tactics to treat tumors can be based on temporary and locally limited effects. In addition, cancer cells have different properties than normal cells and this allows for targeting gene therapy to specific cells, a major advantage over current antitumor therapies, which are also toxic to normal cells and tissues.Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 484 pp. Englisch.